Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (351-360 of 418) with videos related to

Pageof 42
Sort By:
International Journal of Cancer|July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trialStefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
Tumori|April 4, 2013
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
The Lancet. Oncology|April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trialSandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
Tumori|March 11, 2011
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2012
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsMassimo Di Maio, Simona Signoriello, Alessandro Morabito, et al.
Frontiers in Medicine|December 26, 2022
A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trialValentina D'Angelo, Maria Carmela Piccirillo, Massimo Di Maio, et al.
JAMA Oncology|May 18, 2023
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical TrialStefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLCAndrea Ardizzoni, Marcello Tiseo, Luca Boni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2020
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino studyAlessandra Raimondi, Massimo Di Maio, Federica Morano, et al.
Cancers|November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal CancersMaurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
Pageof 42

Showing results (351-360 of 418) with videos related to

Sort By:
Pageof 42
International Journal of Cancer|July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trialStefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
Tumori|April 4, 2013
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
The Lancet. Oncology|April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trialSandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
Tumori|March 11, 2011
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM)Stefania Gori, Massimo Di Maio, Carmine Pinto, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2012
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsMassimo Di Maio, Simona Signoriello, Alessandro Morabito, et al.
Frontiers in Medicine|December 26, 2022
A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trialValentina D'Angelo, Maria Carmela Piccirillo, Massimo Di Maio, et al.
JAMA Oncology|May 18, 2023
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical TrialStefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLCAndrea Ardizzoni, Marcello Tiseo, Luca Boni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2020
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino studyAlessandra Raimondi, Massimo Di Maio, Federica Morano, et al.
Cancers|November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal CancersMaurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
Pageof 42